Spots Global Cancer Trial Database for Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer Patients

Official Title: Prospective Non-randomized Evaluation of Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer Patients

Study ID: NCT02376413

Conditions

Local Recurrence of Malignant Tumor of Breast

Interventions

Breast surgery

Chemotherapy or endocrine therapy or Trastuzumab therapy

Radiation therapy

Study Description

Brief Summary: Breast-conserving surgery (BCS) is the traditional surgical treatment for early-stage breast cancer patients. There are evidences indicating that oncoplastic-BCS (displacement technique) could improve cosmetic outcomes and/or quality of life, and has similar oncological safety as traditional BCS does. However, there are no prospective trial comparing oncoplastic-BCS vs. traditional BCS in terms of cosmetic outcomes and oncological safety. In this study, the investigators are going to address this issue by assigning patients into traditional and oncoplastic-BCS group, based on their preference.

Detailed Description: